$30,000 of CENCORA INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands"
You can find more data on corporate lobbying on Quiver Quantitative.
COR Congressional Stock Trading
Members of Congress have traded $COR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $COR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
COR Insider Trading Activity
COR insiders have traded $COR stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $COR stock by insiders over the last 6 months:
- STEVEN H COLLIS (Executive Chairman) has made 0 purchases and 6 sales selling 104,243 shares for an estimated $30,239,518.
- ROBERT P. MAUCH (President & CEO) has made 0 purchases and 6 sales selling 29,940 shares for an estimated $8,750,667.
- SILVANA BATTAGLIA (Executive Vice President) sold 4,077 shares for an estimated $1,212,520
- LAZARUS KRIKORIAN (SVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $866,880.
- LON R GREENBERG sold 3,000 shares for an estimated $837,150
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COR Hedge Fund Activity
We have seen 643 institutional investors add shares of COR stock to their portfolio, and 558 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WALGREENS BOOTS ALLIANCE, INC. removed 2,907,000 shares (-28.0%) from their portfolio in Q2 2025, for an estimated $871,663,950
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,852,742 shares (-19.2%) from their portfolio in Q2 2025, for an estimated $555,544,688
- WELLINGTON MANAGEMENT GROUP LLP removed 1,565,419 shares (-28.9%) from their portfolio in Q2 2025, for an estimated $469,390,887
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,422,450 shares (-85.8%) from their portfolio in Q2 2025, for an estimated $426,521,632
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,373,648 shares (+inf%) to their portfolio in Q2 2025, for an estimated $411,888,352
- CITADEL ADVISORS LLC added 1,172,066 shares (+193.4%) to their portfolio in Q2 2025, for an estimated $351,443,990
- VANGUARD GROUP INC added 1,125,661 shares (+5.3%) to their portfolio in Q2 2025, for an estimated $337,529,450
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COR Analyst Ratings
Wall Street analysts have issued reports on $COR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 06/03/2025
- Citigroup issued a "Buy" rating on 05/08/2025
- Baird issued a "Outperform" rating on 05/08/2025
- UBS issued a "Buy" rating on 04/29/2025
To track analyst ratings and price targets for COR, check out Quiver Quantitative's $COR forecast page.
COR Price Targets
Multiple analysts have issued price targets for $COR recently. We have seen 6 analysts offer price targets for $COR in the last 6 months, with a median target of $342.5.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $354.0 on 08/13/2025
- Erin Wright from Morgan Stanley set a target price of $330.0 on 07/16/2025
- Jonathan Petersen from Jefferies set a target price of $300.0 on 06/30/2025
- Michael Rollins from Citigroup set a target price of $355.0 on 05/08/2025
- David Rodgers from Baird set a target price of $350.0 on 05/08/2025
- Kevin Caliendo from UBS set a target price of $335.0 on 04/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
